공지사항

Lung cancer lung Mesothelioma

Although they share similar symptoms mesothelioma, lung cancer and mesothelioma are two distinct conditions. Mesothelioma, a form of cancer, develops in the membrane that surrounds organs and structures, which includes the lungs.

Doctors take fluid samples from the pleural spaces and CT scans to diagnose mesothelioma. They may also conduct lung biopsy, or a VATS procedure which uses keyhole surgery for tissue removal.

Symptoms

Mesothelioma, a rare cancerous condition, develops within the thin layer that protects your internal organs. The most frequent type, pleural mesothelioma, forms in the lining of your lung (pleura). The cancer is caused by asbestos fibers blown into the lungs. This causes irritation and scarring.

The first signs of pleural mesothelioma include chest pain, difficulty breathing, and dry cough. These symptoms are similar to other lung diseases, and so mesothelioma is often overlooked until it has reached a late stage.

As mesothelioma advances, it becomes more difficult to breath and sufferers experience fatigue, weight loss, nausea and fever. Other symptoms, like swelling of the arms or face and a lump on the chest, may be a sign of mesothelioma. In the last stages of mesothelioma, patients may have night sweats and anemia.

Doctors diagnose mesothelioma by reviewing the medical history of a patient and performing a physical examination. They also conduct imaging tests to identify cancerous tumors or other signs of mesothelioma. In some cases, doctors may insert a tube in the chest to drain fluid that has accumulated there. They can also request blood tests to measure the levels of certain proteins that are more prevalent in mesothelioma patients. These biomarkers can be used to distinguish mesothelioma from lung cancer.

Diagnosis

When mesothelioma first gets diagnosed, it is usually in its late stage and is difficult for doctors to distinguish it from other lung cancers. Mesothelioma as well as lung cancer have similar symptoms, for example, difficulty breathing, chest pressure and an increase in lungs' fluid. Many doctors do not detect mesothelioma until it has advanced or reaches a late stage.

The location of mesothelioma can be classified. Pleural mesothelioma occurs in the lining surrounding the lungs. The other less common forms include peritoneal mesothelioma which is found in the lining of the abdomen, and testicular mesothelioma.

In mesothelioma, the cells transform into tumors and spread to the surrounding tissues. Mesothelioma is more insidious than other lung cancers. A doctor will collect an organ sample to search for mesothelial cells under a microscope. With this information doctors can determine whether the patient is suffering from mesothelioma, or lung cancer.

A blood test can also identify if the patient suffers from mesothelioma. It looks for soluble mesothelin related peptides. These are proteins released into the bloodstream by mesothelial cell. This protein may remain in the blood for many years before mesothelioma shows up in scans or a biopsy. Doctors can also examine the chest Xray for evidence of asbestos exposure such as calcium deposits and Mesothelioma Lung Cancer thickening of the pleura. Doctors can also drain fluid from the pleural cavity with needles to look for cancer cells (thoracentesis).

Treatment

There are many treatment options available to those diagnosed with mesothelioma of the lung. Treatments are dependent on the type of cancer, its location within the body, and the extent of the disease. When choosing a treatment plan doctors will also consider the patient's medical and health history.

Doctors employ various imaging tests to diagnose mesothelioma. They may use chest X-rays and computerized tomography scans. They may also order a biopsy -- the removal of a small sample of tissue to test. They may also conduct the lung cancer from asbestos function and blood test to determine if there are biomarkers that can indicate mesothelioma's presence.

Malignant mesothelioma can be classified into three categories based on how the cells look under a microscope. The three categories are epithelioid sarcomatoid, Mesothelioma Lung Cancer and mixed. Each one of these categories has different survival rates and treatment options.

Most often, mesothelioma will be diagnosed at a late stage. This is the time when surgery is not an option. Therefore, doctors focus on controlling the symptoms to make patients as comfortable as possible. This is referred to as palliative care.

Patients with mesothelioma could also think about participating in a clinical study. These research studies help improve existing treatment options and develop new ones. A mesothelioma expert can assist patients find the appropriate study and discuss treatment options.

Prognosis

The survival rate risk of lung cancer malignant mesothelioma depends on the type and stage of the tumor at the time of diagnosis. Other factors include the general health of the patient and the treatment option chosen. Mesothelioma can spread to other parts of the body which is called metastasis. It could also recur after it has been treated.

The mesothelium membrane covers a variety of cavities in the body. It is most often found in the lining of the lungs (pleura) but can also form in the abdomen's lining or around the heart.

Shortness of breath, chest pain, and other symptoms can be caused by mesothelioma lung cancer. The symptoms may be similar to those from other diseases. It is imperative to consult a doctor for any concerns.

Tests can help in diagnosing mesothelioma. A doctor could order a CT scan or MRI in order to check for changes in the lungs, such as the pleural thickening process or pleural effusion. These are accumulation of fluid. It is also possible to do an positron emission (PET) scan. This test involves giving a shot the radioactive compound taken up by cancer cells. The doctors can then see the area that has the most cancerous tissue on the PET image.

Patients suffering from mesothelioma may opt to take part in a clinical study for treatment. These studies are designed to improve existing treatments and introduce new ones.